01 Apr 2026
PBS Update: Macrogol 3350 Access Changes from 1 April 2026
From 1 April 2026, the PBS has updated the access rules for macrogol 3350 (sachets 13.125 g with electrolytes, 30) and its listed brands.
01 Apr 2026
PBS Update: Easier Access to Combination Blood Pressure Medicines
From 1 April 2026, changes to the Pharmaceutical Benefits Scheme (PBS) make it easier for Australians to access fixed-dose combination (FDC) medicines to treat high blood pressure.
25 Mar 2026
Have Your Say on New Medicines – PBAC Meeting July 2026
The agenda for the Pharmaceutical Benefits Advisory Committee (PBAC) meeting in July 2026 is now available.
01 Mar 2026
PBS Broadens Nivolumab and Ipilimumab Access from 1 March 2026
From 1 March 2026, the PBS will expand listings for nivolumab and ipilimumab, allowing wider use for patients with advanced or metastatic cancers.
12 Feb 2026
New Medicines and Vaccines Under Review by PBAC
The Pharmaceutical Benefits Advisory Committee (PBAC) has published its latest meeting agenda, outlining which medicines and vaccines are being considered for listing or changes under the Pharmaceutical Benefits Scheme (PBS) and the National Immunisation Program (NIP).
01 Feb 2026
PBS Updates – Feb 2026
The PBS website has the newest information on medicines, highlighting new, updated, and removed items.
09 Jan 2026
PBAC Invites Consumer Comments for March 2026 Meeting
Closing date for comments: Wednesday, 21 January 2026
01 Oct 2025
1 October 2025 Designated Brand List – Minimum Stockholding Requirements
1 October 2025 Designated Brand List – Minimum Stockholding Requirements
23 Sep 2025
Outcome Statement for August 2025 Pulmonary Arterial Hypertension Stakeholder Meeting Released
Outcome Statement for August 2025 Pulmonary Arterial Hypertension Stakeholder Meeting Released